Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled...

Area of Science:

• Pharmacology
• Cardiology
• Pulmonology

Background:

• Beta-adrenergic blocking agents (beta-blockers) are widely used for cardiovascular conditions.
• A significant adverse effect of beta-blockers is the potential for asthma exacerbation.
• Identifying beta-blockers with a higher risk of asthma attacks is crucial for patient safety.

Purpose of the Study:

• To compare the risk of asthma attacks associated with various beta-blockers.
• To identify specific beta-blockers that pose a higher risk for asthma exacerbation.

Main Methods:

• A network meta-analysis (NMA) was conducted using data from 24 randomized controlled trials (RCTs).
• The analysis followed a frequentist model, comparing beta-blockers against placebo.
• The primary outcome measured was the incidence of asthma attacks.

Main Results:

• Oral timolol and infusion of propranolol were significantly associated with a higher incidence of asthma attacks compared to placebo.
• Several other beta-blockers, including oral celiprolol, bisoprolol, and atenolol, showed a trend towards lower asthma attack incidence.
• In patients with a history of asthma, oral timolol, infusion propranolol, oral labetalol, oxprenolol, propranolol, and metoprolol showed increased asthma attack risk.

Conclusions:

• Oral timolol and infusion of propranolol are linked to a significantly higher risk of asthma attacks.
• These specific beta-blockers should be avoided in patients with a predisposition to asthma.
• Further research may explore safer alternatives for cardiovascular patients with respiratory conditions.